HOME >> MEDICINE >> NEWS
GSK's Pazopanib shows positive results in patients with advanced renal cell carcinoma

CHICAGO June 2, 2007 -- GlaxoSmithKline (GSK) today announced results from ongoing Phase II studies of pazopanib in advanced or metastatic renal cell carcinoma (RCC). These trials were presented at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. The results observed in these trials with pazopanib support further investigations.

Pazopanib is an oral, investigational angiogenesis inhibitor targeting vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and c-kit, important proteins in the angiogenic process. Angiogenesis, which is the growth of new blood vessels in the body, plays a critical role in the growth and spread of tumors. ,

Renal cell carcinoma study (Abstract 5031)
DATA EMBARGOED UNTIL SATURDAY JUNE 2, 8AM CDT

This ongoing Phase II randomized discontinuation study is evaluating patients with advanced or metastatic RCC who have not received prior systemic therapy or have failed one prior therapy (cytokine or bevacizumab-containing regimen). All patients received 800 mg of pazopanib taken orally, once-daily during a 12 week lead-in period. Based on data available on 60 patients at the time of a planned interim analysis, the Independent Data Monitoring Committee (IDMC) recommended that randomization to placebo for patients with stable disease should be discontinued. The study continued as an open-label, single-arm study with all patients receiving pazopanib.

The preliminary week 12 response rate for all 225 patients was 27%. In addition, stable disease was achieved in 46% of patients for a total disease control rate of 73%. Responses have been observed beyond week 12, and the overall response rate will be reported at study completion. Response was determined according to RECIST (Response Evaluation Criteria In Solid Tumors) which is a set of published rules that defines when cancer patients improve
'"/>

Contact: Stephanie Gardner
steph.gardner@toniclc.com
020-779-89929
GAEA Initiative
2-Jun-2007


Page: 1 2 3

Related medicine news :

1. GSKs Pazopanib shows positive results in patients with advanced RCC and ovarian cancer
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Most seniors now have drug coverage, U-M study shows
4. Wireless technology shows promise in diagnosing pediatric intestinal disease
5. Study shows radiofrequency ablation highly effective in treating kidney tumors
6. Method shows promise for early detection of pancreatic cancer
7. Organic farming can feed the world, U-M study shows
8. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
9. Borderline personality disorder shows improvements with intensive psychotherapy
10. New drug shows promise in treatment of advanced thyroid cancer
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 10, 2020 , ... Inversion therapy is defined ... out the spine and relieve back pain.” Ergo, the theory is that if the ... while implementing traction for the spine using the head and upper body as the ...
(Date:7/10/2020)... CHICAGO (PRWEB) , ... July 09, 2020 , ... Ziegler, ... 2020 Bank Bonds for Michigan Christian Home d/b/a Beacon Hill at Eastgate (Beacon Hill). ... amortization and a $12,700,000 short-term loan with a 3-year amortization that will be retired ...
(Date:7/7/2020)... ... 2020 , ... Dr. Louis M. DeJoseph is proud to announce ... health. It is now possible to receive Keravive treatments from HydraFacial at the Premier ... DeJoseph is able to provide clients with the best services to help them look ...
(Date:7/4/2020)... ... July 03, 2020 , ... MemoryCare.com , ... announced the Best Memory Care Facilities in Charleston, South Carolina. The guide identifies ... amenities. , According to the Alzheimer’s Association , 5.6 million people ...
(Date:7/2/2020)... ... July 02, 2020 , ... The Coronavirus ... for non-emergency work. In conjunction with the American Dental Association and Centers for ... in mid-May. , Due to safety concerns, the announcement sparked hesitancy among ...
Breaking Medicine News(10 mins):
(Date:7/2/2020)... ... July 02, 2020 , ... Gulf Coast ... announce its donation of more than $190,000 in personal protective equipment (PPE) to ... Services. As extreme medical shortages continue to plague the nation’s communities and healthcare ...
(Date:6/28/2020)... (PRWEB) , ... June 28, 2020 , ... ... digestive health. New studies substantiate the effectiveness of oral-care probiotics to maximize ... probiotics? While the science behind both is simple – utilizing naturally occurring ...
(Date:6/25/2020)... NEW YORK (PRWEB) , ... June 25, 2020 ... ... provider by leading industry analysts Top App Developers & DesignRush following the launch ... on the first comprehensive exercise/community platform for cancer survivors. , Commissioned by ...
Breaking Medicine Technology:
Cached News: